Malignant Lymphoma - Lymphoplasmacytic: Clinical Trials

1 trial for Malignant Lymphoma - Lymphoplasmacytic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Malignant Lymphoma - Lymphoplasmacytic: new trials by email Literature Review of Malignant Lymphoma - Lymphoplasmacytic trials Research Report on Malignant Lymphoma - Lymphoplasmacytic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of Doxycycline in Relapsed NHL
Doxycycline - Adult Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma Recurrent
Phase 2TerminatedUniversity of Rochester72014-03-012016-12-22

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Waldenstrom Macroglobulinemia (1)

Broader conditions

Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)

Interventions

Doxycycline (1)

Sponsors

University of Rochester (1)

Countries

United States (1)

Top investigators

Carla Casulo, MD (1)